STEM CELL–BASED MYOCARDIAL REGENERATION AFTER INFARCTION: MOLECULAR MECHANISMS, TRANSLATIONAL CHALLENGES, AND EMERGING BIOTECHNOLOGICAL INNOVATIONS

Amanda Abramowicz; Maja Osuch; Maciej Osuch; Olga Tatarata; Martyna Jaciubek; Carmena Luty; Anna Kiełboń; Zuzanna Olga Reklewska; Kornelia Domagała; Magdalena Rumin

doi:10.31435/ijitss.1(49).2026.5045

Authors

Amanda Abramowicz Military Institute of Aviation Medicine, Warsaw, Mazovia, Poland https://orcid.org/0009-0004-6674-0594
Maja Osuch 4th Military Clinical Hospital with Polyclinic SPZOZ in Wrocław, Wrocław, Poland https://orcid.org/0009-0000-9815-2608
Maciej Osuch 4th Military Clinical Hospital with Polyclinic SPZOZ in Wrocław, Wrocław, Poland https://orcid.org/0009-0009-2399-2878
Olga Tatarata Military Institute of Aviation Medicine, Warsaw, Mazovia, Poland https://orcid.org/0009-0007-1279-7394
Martyna Jaciubek Military Institute of Aviation Medicine, Warsaw, Mazovia, Poland https://orcid.org/0009-0002-5520-0002
Carmena Luty 118th Military Hospital with Polyclinic SPZOZ in Ełk, Poland https://orcid.org/0009-0007-6084-0385
Anna Kiełboń Military Institute of Medicine in Warsaw, Mazovia, Poland https://orcid.org/0009-0004-9028-6395
Zuzanna Olga Reklewska The Military Medical Training Center, Łódź, Poland https://orcid.org/0009-0008-3539-646X
Kornelia Domagała 7th Naval Hospital in Gdańsk, Gdańsk, Poland https://orcid.org/0009-0008-4148-9320
Magdalena Rumin Military Institute of Aviation Medicine, Warsaw, Mazovia, Poland https://orcid.org/0009-0009-4281-8971

DOI:

https://doi.org/10.31435/ijitss.1(49).2026.5045

Keywords:

Stem Cell Therapy, Cardiac Regeneration, Regenerative Biotechnology, Exosome Engineering, Tissue Engineering, Translational Medicine

Abstract

Myocardial infarction (MI) remains a major global health burden, driving substantial healthcare costs and long-term societal impact due to progressive heart failure and reduced quality of life. Conventional therapies improve survival but do not restore lost myocardial tissue. Stem cell–based cardiac regeneration represents a disruptive biomedical innovation situated at the intersection of biotechnology, translational medicine, and health systems transformation. This review examines contemporary regenerative strategies—including mesenchymal stromal cells, induced pluripotent stem cells, and cardiac progenitor cells—with emphasis on their underlying molecular mechanisms and technological advancements. Particular attention is given to exosome engineering, gene-modified stem cells, biomaterial-assisted delivery systems, hydrogel scaffolds, and tissue-engineered cardiac patches. Evidence from preclinical and clinical studies indicates functional improvements mediated predominantly through paracrine signaling, angiogenic stimulation, and immunomodulatory regulation rather than direct cardiomyocyte replacement. However, technological scalability, manufacturing standardization under GMP conditions, safety concerns, regulatory frameworks, and cost-effectiveness remain critical barriers to widespread implementation. The integration of regenerative cardiology with bioengineering, nanotechnology, and precision medicine may enable more sustainable and accessible therapeutic models. By situating stem cell–based cardiac repair within a broader innovation ecosystem, this review highlights both the transformative potential and the systemic challenges associated with next-generation cardiovascular therapies.

References

Bolli, R. (2016). Repeated cell therapy paradigm for ischemic heart disease. Circulation Research, 118(7), 1094–1096. https://doi.org/10.1161/CIRCRESAHA.116.308203

Cambria, E., Pasqualini, F. S., Wolint, P., et al. (2017). Translational cardiac tissue engineering: Advanced models and regenerative strategies. Circulation Research, 120(8), 1247–1260. https://doi.org/10.1161/CIRCRESAHA.116.309538

Cheng, K., Malliaras, K., Li, T. S., et al. (2010). Magnetic targeting enhances engraftment and functional benefit of mesenchymal stem cells in infarcted myocardium. Circulation, 122(11 Suppl), S98–S106. https://doi.org/10.1161/CIRCULATIONAHA.109.928515

Chong, J. J. H., Yang, X., Don, C. W., et al. (2014). Human embryonic stem cell–derived cardiomyocytes regenerate non-human primate hearts. Nature, 510(7504), 273–277. https://doi.org/10.1038/nature13233

Dominici, M., Le Blanc, K., Mueller, I., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. Cytotherapy, 8(4), 315–317. https://doi.org/10.1080/14653240600855905

Dorn, G. W., & Molkentin, J. D. (2004). Apoptosis in cardiac disease. Circulation, 109(12), 1509–1513. https://doi.org/10.1161/01.CIR.0000128492.24761.58

Eschenhagen, T., & Weinberger, F. (2024). Challenges of heart repair with pluripotent stem cell–derived cardiomyocytes. Nature Cardiovascular Research, 3(6), 515–524. https://doi.org/10.1038/s44161-024-00256-5

Frangogiannis, N. G. (2015). Pathophysiology of myocardial infarction. Circulation Research, 116(5), 848–865. https://doi.org/10.1161/CIRCRESAHA.116.303535

9.Gallet, R., Dawkins, J., Valle, J., et al. (2017). Exosomes secreted by cardiosphere-derived cells reduce scar size and improve function in porcine myocardial infarction. Stem Cells, 35(4), 1154–1167. https://doi.org/10.1002/stem.2568

Gyongyosi, M., Wojakowski, W., Lemarchand, P., et al. (2015). Meta-analysis of cell-based cardiac studies in acute myocardial infarction. Circulation Research, 116(8), 1346–1360. https://doi.org/10.1161/CIRCRESAHA.116.304346

Hare, J. M., Traverse, J. H., Henry, T. D., et al. (2012). A randomized comparison of allogeneic versus autologous mesenchymal stem cells for ischemic cardiomyopathy. JAMA, 308(22), 2369–2379. https://doi.org/10.1001/jama.2012.25321

Hausenloy, D. J., & Yellon, D. M. (2013). Myocardial ischemia–reperfusion injury: A neglected therapeutic target. Cardiovascular Research, 99(1), 1–13. https://doi.org/10.1093/cvr/cvt044

Ibrahim, A. G., Cheng, K., & Marbán, E. (2014). Exosomes as critical agents of cardiac repair. Circulation Research, 114(11), 1757–1764. https://doi.org/10.1161/CIRCRESAHA.114.303614

Jiang, X., Lian, X., Wei, K., et al. (2024). Maturation of pluripotent stem cell–derived cardiomyocytes: Mechanisms and translational implications. Stem Cell Research & Therapy, 15(1), 354. https://doi.org/10.1186/s13287-024-03540-7

Khan, M., Nickoloff, E., Abramova, T., et al. (2015). Embryonic stem cell–derived exosomes promote cardiac repair. Circulation Research, 117(1), 52–64. https://doi.org/10.1161/CIRCRESAHA.117.305990

Madonna, R., Van Laake, L. W., Davidson, S. M., et al. (2020). Mesenchymal stem cells and angiogenesis. Cardiovascular Research, 116(6), 1142–1154. https://doi.org/10.1093/cvr/cvaa046

McDonagh, T. A., Metra, M., Adamo, M., et al. (2021). 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 42(36), 3599–3726. https://doi.org/10.1093/eurheartj/ehab368

Prabhu, S. D., & Frangogiannis, N. G. (2016). The biological basis for cardiac repair after myocardial infarction. Circulation Research, 119(1), 91–112. https://doi.org/10.1161/CIRCRESAHA.116.303577

Segers, V. F., & Lee, R. T. (2008). Stem-cell therapy for cardiac disease. Nature, 451(7181), 937–942. https://doi.org/10.1038/nature06800

Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells by defined factors. Cell, 126(4), 663–676. https://doi.org/10.1016/j.cell.2006.07.024

Tang, Y. L., Zhao, Q., Zhang, Y. C., et al. (2004). Autologous mesenchymal stem cell transplantation improves cardiac function in a rat model of myocardial infarction. Circulation, 110(11 Suppl 1), II-268–II-275. https://doi.org/10.1161/01.CIR.0000138399.84365.3A

Tseliou, E., & Terrovitis, J. (2022). Cardiac progenitor cells revisited: Current evidence and future perspectives. Trends in Cardiovascular Medicine, 32(2), 123–131. https://doi.org/10.1016/j.tcm.2021.04.006

Uemura, R., Xu, M., Ahmad, N., & Ashraf, M. (2006). Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circulation, 114(1 Suppl), I-8–I-15. https://doi.org/10.1161/CIRCULATIONAHA.105.000661

Vagnozzi, R. J., Maillet, M., Sargent, M. A., et al. (2020). An acute immune response underlies the benefit of cardiac stem cell therapy. Nature, 577(7790), 405–409. https://doi.org/10.1038/s41586-019-1802-2

Zhang, H., Song, J., Chang, Y., & Zheng, B. (2025). Hydrogel materials in myocardial infarction treatment. RSC Advances, 15, 31564–31585. https://doi.org/10.1039/D5RA01234A

BAMI Investigators. (2020). The effect of intracoronary infusion of bone marrow–derived mononuclear cells on mortality in acute myocardial infarction: The BAMI trial. European Heart Journal, 41(4), 370–379. https://doi.org/10.1093/eurheartj/ehz798

Fisher, S. A., Brunskill, S. J., Doree, C., et al. (2016). Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. Cochrane Database of Systematic Reviews, 12, CD006536. https://doi.org/10.1002/14651858.CD006536.pub4

Forte, E., Skelly, D. A., Chen, M., et al. (2020). Dynamic interstitial cell response during myocardial infarction predicts functional outcome. Cell, 182(1), 1–17. https://doi.org/10.1016/j.cell.2020.05.024

Gao, L., Gregorich, Z. R., Zhu, W., et al. (2018). Large cardiac muscle patches engineered from human induced pluripotent stem cell–derived cardiomyocytes improve recovery from myocardial infarction in swine. Nature Biomedical Engineering, 2(5), 301–311. https://doi.org/10.1038/s41551-018-0227-8

30.Hatzistergos, K. E., Quevedo, H., Oskouei, B. N., et al. (2010). Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circulation Research, 107(7), 913–922. https://doi.org/10.1161/CIRCRESAHA.110.222703

Heldman, A. W., DiFede, D. L., Fishman, J. E., et al. (2014). Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy (TAC-HFT). JAMA, 311(1), 62–73. https://doi.org/10.1001/jama.2013.282909

Ibanez, B., James, S., Agewall, S., et al. (2018). 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal, 39(2), 119–177. https://doi.org/10.1093/eurheartj/ehx393

Kavousi, S., Hosseinpour, A., Jahromi, F. B., et al. (2024). Mesenchymal stem cell transplantation in heart failure: A meta-analysis of randomized trials. Journal of Translational Medicine, 22(1), 786. https://doi.org/10.1186/s12967-024-04567-3

Kim, Y. J., et al. (2021). Clinical-grade mesenchymal stem cell manufacturing under GMP conditions: Standardization and translational considerations. Stem Cells Translational Medicine, 10(6), 913–922. https://doi.org/10.1002/sctm.20-0485

Luger, D., Lipinski, M. J., Westman, P. C., et al. (2017). Intravenous mesenchymal stem cells improve myocardial function and reduce inflammation after myocardial infarction. Journal of the American College of Cardiology, 69(3), 288–299. https://doi.org/10.1016/j.jacc.2016.10.050

Madonna, R., et al. (2019). Mesenchymal stem cells and myocardial homing mechanisms. Frontiers in Cell and Developmental Biology, 7, 16. https://doi.org/10.3389/fcell.2019.00016

Marbán, E. (2018). Breakthroughs in cell therapy for heart disease. Circulation Research, 123(2), 139–141. https://doi.org/10.1161/CIRCRESAHA.118.313205

Menasché, P. (2018). Cell therapy trials for heart regeneration—Lessons learned and future directions. European Heart Journal, 39(21), 188–190. https://doi.org/10.1093/eurheartj/ehx816

Sensebé, L., Bourin, P., & Tarte, K. (2013). Clinical grade production of mesenchymal stem cells. Cytotherapy, 15(2), 105–116. https://doi.org/10.1016/j.jcyt.2012.10.005

Shahannaz, D. C., Sugiura, T., Ferrell, B. E., & Yoshida, T. (2025). Arrhythmogenic risk associated with iPSC-derived cardiomyocyte transplantation. Medicina, 61(12),2056.https://doi.org/10.3390/medicina61122056

Wan, X., Qian, C., Liu, S., et al. (2025). Stem cell therapy for myocardial infarction and atherosclerosis: Mechanistic insights and clinical implications. Stem Cell Research & Therapy, 16, 551. https://doi.org/10.1186/s13287-025-05551-9

Yan, W., Xia, Y., Zhao, H., et al. (2024). Stem cell-based therapy in cardiac repair after myocardial infarction. Journal of Molecular and Cellular Cardiology, 188, 1–14. https://doi.org/10.1016/j.yjmcc.2023.12.001

Zhao, M., Xue, Y., Tian, Q., et al. (2025). Mesenchymal stem cell therapy in acute myocardial infarction: Updated meta-analysis. Cell Transplantation, 34, 09636897251359773. https://doi.org/10.1177/09636897251359773

Bolli, R., Chugh, A. R., D’Amario, D., et al. (2011). Cardiac stem cells in patients with ischemic cardiomyopathy (SCIPIO): Initial results of a randomized phase 1 trial. The Lancet, 378(9806), 1847–1857. https://doi.org/10.1016/S0140-6736(11)61590-0

Ellison, G. M., Vicinanza, C., Smith, A. J., et al. (2013). Adult c-kit+ cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell, 154(4), 827–842. https://doi.org/10.1016/j.cell.2013.07.039

Eschenhagen, T., Bolli, R., Braun, T., et al. (2017). Cardiomyocyte regeneration: A consensus statement. Circulation, 136(7), 680–686. https://doi.org/10.1161/CIRCULATIONAHA.117.029343

Frangogiannis, N. G. (2017). The extracellular matrix in myocardial infarction. Circulation Research, 121(7), 847–861. https://doi.org/10.1161/CIRCRESAHA.117.311148

Heldman, A. W., & Hare, J. M. (2018). Cell therapy for heart disease: A review of clinical trials. Circulation Research, 123(2), 132–138. https://doi.org/10.1161/CIRCRESAHA.118.312131

Heusch, G. (2020). Myocardial ischemia–reperfusion injury and cardioprotection. Circulation Research, 126(5), 711–729. https://doi.org/10.1161/CIRCRESAHA.119.315958

Karantalis, V., & Hare, J. M. (2015). Use of mesenchymal stem cells for therapy of cardiac disease. Circulation Research, 116(8), 1413–1430. https://doi.org/10.1161/CIRCRESAHA.116.305956

Laflamme, M. A., & Murry, C. E. (2011). Heart regeneration. Nature, 473(7347), 326–335. https://doi.org/10.1038/nature10147

Leuschner, F., Rauch, P. J., Ueno, T., et al. (2012). Rapid monocyte kinetics in acute myocardial infarction. The Journal of Clinical Investigation, 122(4), 1382–1394. https://doi.org/10.1172/JCI59867

Liu, B., Lee, B. W., Nakanishi, K., et al. (2018). Cardiac recovery via exosome-mediated mitochondrial transfer. Circulation Research, 122(7), 1000–1015. https://doi.org/10.1161/CIRCRESAHA.117.311599

Marbán, E. (2018). The secret life of exosomes: What bees can teach us about next-generation therapeutics. Circulation Research, 122(2), 156–158. https://doi.org/10.1161/CIRCRESAHA.117.312000

Menasché, P., Vanneaux, V., Fabreguettes, J. R., et al. (2015). Towards a clinical use of human embryonic stem cell–derived cardiac progenitors. European Heart Journal, 36(12), 743–750. https://doi.org/10.1093/eurheartj/ehu455

Nguyen, P. K., Rhee, J. W., Wu, J. C. (2016). Adult stem cell therapy and heart failure, 2000–2016: A systematic review. JAMA Cardiology, 1(7), 831–841. https://doi.org/10.1001/jamacardio.2016.2225

Passier, R., van Laake, L. W., & Mummery, C. L. (2008). Stem-cell–based therapy and lessons from the heart. Nature, 453(7193), 322–329. https://doi.org/10.1038/nature07040

Sanganalmath, S. K., & Bolli, R. (2013). Cell therapy for heart failure: A comprehensive overview. Circulation Research, 113(6), 810–834. https://doi.org/10.1161/CIRCRESAHA.113.300219

van der Spoel, T. I., Jansen of Lorkeers, S. J., Agostoni, P., et al. (2011). Human relevance of pre-clinical stem cell models. European Heart Journal, 32(24), 3055–3063. https://doi.org/10.1093/eurheartj/ehr249

Vo, Q. D., Saito, Y., Nakamura, K., et al. (2024). iPSC-derived cardiomyocyte therapy for myocardial infarction: A meta-analysis of preclinical data. International Journal of Molecular Sciences, 25(3), 987. https://doi.org/10.3390/ijms25030987

Wang, Y., Qi, Z., Yan, Z., et al. (2022). Mesenchymal stem cell immunomodulation in cardiovascular disease. Frontiers in Cell and Developmental Biology, 9, 742088. https://doi.org/10.3389/fcell.2021.742088

Xu, C., Xie, Y., Wang, B. (2024). Genetically modified mesenchymal stromal cells for myocardial infarction. Stem Cell Research & Therapy, 15, 323. https://doi.org/10.1186/s13287-024-03489-7

Zhang, Y., Mignone, J., MacLellan, W. R. (2015). Cardiac regeneration and stem cells. Physiological Reviews, 95(4), 1189–1204. https://doi.org/10.1152/physrev.00021.2014